Further developments for improving response and tolerance to irradiation for advanced renal cancer: Concurrent (mTOR) inhibitor RAD001 and helical tomotherapy

Investigational New Drugs

Volumn 30, Issue 3, 2012, Pages 1241-1243

  Kirova, Youlia M ^a   Servois, Vincent ^a   Chargari, Cyrus ^a,c   Amessis, Malika ^a   Zerbib, Marc ^b   Beuzeboc, Philippe ^a  

^a INSTITUT CURIE   (France)

^b Institut Cochin   (France)

^c University of Paris Descartes   (France)

Author keywords

Advanced renal cancer; Early toxicity; Helical tomotherapy; mTOR inhibitor

Indexed keywords

EVEROLIMUS; SORAFENIB; SUNITINIB;

ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER METASTASIS; MALE; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RADIATION DOSE DISTRIBUTION; RETROPERITONEAL CANCER; SKIN DISEASE; TOMOTHERAPY; TREATMENT RESPONSE;

AGED; COMBINED MODALITY THERAPY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY NEOPLASMS; MALE; RADIOTHERAPY, INTENSITY-MODULATED; SIROLIMUS; TOMOGRAPHY, SPIRAL COMPUTED; TOR SERINE-THREONINE KINASES;

EID: 84864357221     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-010-9613-1     Document Type: Article

References (9)

1. Suárez C, Morales R, Muñoz E, Rodón J, Valverde CM, Carles J (2010) Molecular basis for the treatment of renal cell carcinoma. Clin Transl Oncol 12:15-21
2. Basso M, Cassano A, Barone C (2010) A survey oftherapy for advanced renal cell carcinoma. Urol Oncol 28:121-133
3. Murphy JD, Spalding AC, Somnay YR, Markwart S, Ray ME, Hamstra DA (2009) Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature. Clin Cancer Res 15:589-596
4. Chen H, Ma Z, Vanderwaal RP, Feng Z, Gonzalez-Suarez I, Wang S, Zhang J, Roti Roti JL, Gonzalo S, Zhang J (2010) The mTOR inhibitor rapamycin suppresses DNA double-strand break repair. Radiat Res (in press)
5. Chargari C, Campana F, Beuzeboc P, Zefkili S, Kirova YM (2009) Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer. World J Gastroenterol 15:4444-4445
6. Kirova YM, Chargari C, Zefkili S, Campana F (2010) Could helical tomotherapy do whole brain radiotherapy and radiosurgery? World J Radiol 2:148-150
7. Chargari C, Kirova YM, Zefkili S et al (2009) Solitary plasmocytoma: improvement in critical organs sparing by means ofhelical tomotherapy Eur J Haematol 83:66-71
8. Chargari C, Vernant JP, Tamburini J et al (2010) Feasibility ofhelical tomotherapy for debulking irradiation before stem cell transplantation in malignant lymphoma. Int J Radiat Oncol Biol Phys (in press)
9. Bhatt RS, Landis DM, Zimmer M et al (2008) Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor. BJU Int 102:358-363 (Pubitemid 352019187)